Atlas Trials

Isoquercetin in Sickle Cell Anemia

Clinical trial NCT04474626 · WITHDRAWN

Trial details

NCT number
NCT04474626
Sponsor
Jeffrey Zwicker, MD
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell DiseaseSickle Cell-Beta0-Thalassemia
Start date
2020-12-01
Primary completion
2022-12-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.